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MORINGA OLEIFERA LEAVES AQUEOUS EXTRACT INDUCE APOPTOSIS IN HT29 
CELL LINE 
Abstract 
Moringa oleifera (MO) tree has been recognized for the nutritional and medicinal values, attributing anti-
inflammatory, antioxidants, and antidiabetic activities of the alcoholic and/or water extracts to its various 
parts. Recent research has focused on therapeutic anti-cancerous effects of the water extract of MO 
leaves (MOE), commonly consumed as hot beverage. In-vitro cytotoxicity on esophageal, lung, and breast 
cancer cells were reported by MOE. The aim in this study is to investigate the anti-cancerous potential 
of MOE on the colon carcinoma HT29 cells. MO water extract (MOE) was prepared at concentrations 
(0.1%-0.5%). MOE anti-proliferative effect on HT29-cells was assessed by measuring cellular viability 
using trypan blue assay. MOE cytotoxicity was further examined by monitoring the change in levels of 
ROS (NBT assay), ATP (Luciferase assay), and LDH release (cytotoxicity assay) and on depolarization of 
mitochondrial membrane potential (Mito PTTMJC-1). Protective effect of N-Acetyl cysteine and catalase 
were assayed. Cell cycle analysis and Annexin-V/PI staining were also performed to detect cell death. Our 
result showed that MOE induced a dose and time-dependent decrease in viability; increase in ROS and 
LDH release; dissipation of mitochondrial membrane potential with concomitant decrease in ATP level. In 
addition, we obtained an increase in preG0 and late apoptotic events. Pretreatment with the antioxidant 
N-acetyl cysteine suppressed completely LDH release and restored partially and significantly cell viability 
while decreasing ROS level. Catalase was not protective. MOE also induced cell death with related colon 
cancer cell lines: Caco2, SW837, SW948, and HCT116. The induced apoptosis in HT29 cells and related 
CCC identified MOE with anti-cancerous therapeutic potential. 
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Folk Medicine utilizes phytochemicals enriched drug formulation(s) that are derived from 
plants and used in treatment of many ailments including cancer (Balunas & Kinghorn, 2005). World 
health organization has recognized the importance of medicinal plants as curative as well as potential 
source of therapeutic agents (World Health Organization, 1977). The interest in phytochemical 
derived agents have increased significantly in the recent decades. The advantage of using the complex 
mixture of plant extracts over synthetic drugs is their low cost and ability to target multiple sites 
simultaneously, overcoming thus some of the reported side effects of drugs (Gurib-Fakim, 2006). In 
addition, plant derived formulations may differ in composition, texture, and route of administration 
depending on the mode and the extracting solvent that may yield emulsions, solids, liquids or oil. 
Moringa oleifera L. (MO) referred to as the Miracle tree, or “Shagara al Rauwaq” belongs to 
the Moringaceae family (Fahey, 2005; Goyal, et al., 2007; Anwar, et al., 2007). The National Institute 
of Health has highlighted the importance of MO for its nutritive and medicinal values, as well as its 
environmental detoxification ability (National Institutes of Health, 2008). All parts of the plant 
including the seeds, leaves, roots, bark, flowers and pods, are edible and consumed by humans as raw, 
cooked or boiled as drinks (Fuglie, 2001). Compared to other plant species, MO is richer (gram for 
gram) in minerals, essential amino acids, vitamins, and a wide range of phytochemicals: sitosterols, 
quercetin, kaempferol, glucosinolates, and isothiocyanates (Rockwood, et al., 2013; Manguro & 
Lemmen, 2007; Ferreira, et al., 2008). Different pharmacological and biological activities have been 
attributed to different parts of MO. For instance, different studies documented the anti-inflammatory 
(Carceres, et al., 1992), anti-tumorigenic (Elsayed,, et al., 2015), and antimicrobial effects of MO 
seeds (Eilert, et al.,1981; Madsen et al.,1987). Other studies performed on leaves extracted with 
organic solvent showed hypocholesterolemic (Mehta et al., 2003), hypotensive (Gilani et al.,1994), 
anti-ulcerative (Pal et al., 1995), anti-diabetic (Mbikay, 2012), and platelet aggregation inhibitory 
(Arabshahi-Delouee et al., 2009) effects. In addition, to reported evidence in support of the possible 
MO role in regulating blood sugar, and treating cardiovascular disorders (Singh et al.,2009), further 
in vitro and in vivo studies with MO extracts demonstrated hepatoprotective (Sharifudin et al., 2013; 
Pari &  Kumar, 2002), neuroprotective (Ganguly & Guha, 2008), immunomodulatory (Sudha et al., 
2010; Mahajan & Mehta, 2010), diuretic (Carceres et al., 1992), antihypertensive (Faizi et al., 1995; 
Faizi et al.,1998), and anti-carcinogenic effects (Ahmed et al., 2017). 
Cancer is one of the main causes of deaths worldwide (World Health Organization, 2018). 
Although many anti-cancerous drugs have been developed, yet the need to identify new drugs with 
minimal side effects remains a priority in scientific research and pharmaceutical industries. The last 
decade has witnessed the increase in the number of reports documenting evidence, though limited, of 
the anti-proliferative effect of MO. Al-Asmari et al. investigated and compared the effects of alcoholic 
extracts of MO bark, leaves and seeds on breast and colorectal cancerous cell lines (Al-Asmari et al., 
2015). Remarkable anti-cancerous effects were shown, mediated by the decrease in cell motility and 
colony formation in: MDA-MB231 and HCT-8 treated with alcoholic leaves or bark extracts; while 
the seed extracts’ exerted no effect. Another study using the alcoholic MO leaves’ extract documented 
its cytotoxic, antioxidant and anti-proliferative effect on different cell lines: HepG2, Caco-2 and 
MCF-7 (Charoensin, 2014). A similar profile was also obtained with MO leaves’ extract treated 
ovarian and prostate human cancer cell lines (Zayas-Viera & Vivas-Mejia, 2016). Although MO is 
widely used in traditional medicine, there is a limited number of studies on the anti-cancerous effect 
of water extract of MO leaves (MOE) that is highly consumed by people as tea drink. Interestingly, 
the toxicological evaluation of acute-oral administration of MOE showed it is safe (Awodele et al., 
2012) with no mortality occurring at a maximum dose of 2000 mg/kg (Adedapo et al., 2009). Hence 
we opted in this study, to mimic people consumption of MO as tea beverage, (Madi et al., 2016) and 
examine its anti-cancerous potential. In a recent study, we showed a dose dependent decrease in 
viability of MOE-treated A549 cells (human lung adenocarcinoma), induced by compromised 
mitochondrial function, increase in ROS level and PARP -1 cleavage (Madi et al., 2016). 
In the current study, we focused on examining the effect of MOE, mimicking the commonly 
consumed MO-tea drink by people, on colon cancer; one of the leading causes of death affecting 
equally males and females. More specifically, we have investigated the effectiveness and anti-
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2. MATERIALS AND METHODS 
 
Moringa oleifera L. (MO) leaves were supplied by Salah Abdoun, agricultural engineer at 
“Moringa Research and Development Group Farm”, in Khartoum, Sudan. The leaves were deposited 
in the Post Herbarium at the American University of Beirut, under the Voucher number: “Usta 001”. 
Leaves were aerated and dried at room temperature in the dark, then ground, and kept in dark glass 
jars at 4oC. The cell line HT29, a generous gift from Dr. Ralph Abi-Habib, Department of Natural 
Sciences, School of Arts and Sciences at the Lebanese American University, was originally purchased 
from American Type Culture Collection (ATCC), Manassas, VA- USA. The following were supplied 
by Sigma-Aldrich, (Missouri, USA): Roswell Park Memorial Institute Medium (RPMI, cat # R7388), 
Dulbecco’s Modified Eagle’s Medium (DMEM cat # D5796), Heat inactivated fetal bovine serum 
(FBS, cat # F9665), Phosphate Buffered Saline (PBS) solution (10X, cat # D1408), and Trypsin-
EDTA 1X-solution (cat # T3924), 0.4% Trypan Blue Solution (cat # T8154), antioxidants [N-
acetylcysteine (NAC, cat # A9165); Catalase (cat # C3515)] and Propidium Iodide (PI, cat # P4170). 
Penicillin-streptomycin (PEN-Strep mixture, cat # L0022-100) was purchased from Biowest. 
The ATP Bioluminescence Assay Kit HS II (cat # 11 699 709 001), Cell Proliferation Kit I for 
3-(4–5 dimethyl thiazol-2yl)-2, 5 diphenyl tetrazolium bromide (MTT) assay (cat # 11 465 007 001), 
Cytotoxicity Detection Kit PLUS (LDH) (cat # 04 744 934001) were purchased from Roche, 
Mannheim- Germany. Mito PTTMJC-1 kit (cat # ab113850) and Annexin-V FITC Apoptosis 
Detection Kit (cat # ab14085) were purchased from Abcam (USA). P-Nitro Blue Tetrazolium 
Chloride (NBT, cat # 6876) was purchased from MP chemicals, CA-USA. 
 
2.1 Preparation of Moringa oleifera Water Extract (MOE) 
Different concentrations of MOE were prepared by soaking the pulverized leaves (0.1-
0.5g) in boiled dd-H2O (100ml) for 30 min with mild shaking. Extracts were then filtered, 
centrifuged and supernatant was stored as 1ml aliquots at -20ºC.  
Qualitative assessment of different phytochemicals was determined using the indicated 
tests as described in previous reports:  Lead acetate test, shinoda test, honey comb test and ferric 
chloride test (Geetha, and Geetha, 2014); Copper acetate test (Tiwari et al., 2011); Tannic acid 
test and gelatin test (Neelima, et al., 2010). 
 
2.2 Culture of Colon Cancer Cell Lines 
HT29 cells were cultured in humidified CO2 incubator at 37ºC in RPMI and supplemented 
with fetal calf serum (10%) and Pen-Strep (0.5%). Other screened colon cancer cell lines were 
cultured, under the same conditions, using RPMI for HCT116 cells and DMEM for Caco2, 
SW837 and SW948. 
 
2.3 Viability Assay 
Viability of HT29 was determined using trypan blue exclusion assay in which dead cells 
stains blue whereas viable cells remain white. HT29 cells were seeded in 12 well plates 
(1×105cells/ml) and treated for 6 and 24hours with MOE at final well concentrations varying 
from 0.01% to 0.05%. The % viability was determined by computing the ratio of viable cells in 
treated to that of control (untreated cells) multiplied by 100. 
 
2.4 Reactive Oxygen Species (ROS) Level 
HT29 cells were seeded in 96 well plates (1x104/100µl) and treated with MOE at EC50 
(0.03% determined by viability assay) for 3, 6, 12, and 24hours. The level of generated ROS was 
determined as described previously (Muñoz et al., 2000). Briefly, NBT (1mg/ml,100μl) was 
added to control and MOE treated HT29 cells, and incubated for 1hour.  Cells were then washed 
with methanol (100μl/well), and left to dry at room temperature. The formed formazan crystals 
were solubilized by consecutive addition of KOH (2M, 120μl) and DMSO (140μl). Absorbance 
of the developed color was read at 630 nm using Multiskan EX ELISA reader. % ROS generated 
was calculated as follows: 
        % ROS production = 100 - % NBT 








2.5 Lactate Dehydrogenase (LDH) Release 
Cytotoxicity induced in MOE-treated HT29 cells was monitored using LDH release assay 
kit (ROCHE). Disturbance in the plasma membrane integrity causes the release of cytoplasmic 
LDH into the culture media. HT29 cells were seeded in 96 well plates (1x104cells/100µl), and 
treated with MOE (0.03%) for 6 and 24hours. The % release of cytosolic LDH into the culture 
media was determined by assessing the enzymatic conversion of tetrazolium salt into red 
formazan, compared to 3-controls: cell free control, low control (spontaneous release of LDH), 
and high control (maximum release of LDH). The intensity of developed color was read at 492 
nm using Multiskan EX ELISA reader. 
 % LDH released: (Abs of treated cells - Abs of low control) X 100 
                              (Abs of high control - Abs of low control) 
 
2.6 Intracellular ATP Level  
The intracellular ATP level was determined in both MOE-treated HT29 cells and untreated 
control cells using the ATP Bioluminescence Assay Kit. Cells were seeded in 12-well plate 
(1x105cells/1ml) and treated with MOE (0.03%) for 3, 6, 12, and 24hours. Subsequently, cells 
were trypsinized, centrifuged, washed twice with 1X PBS, and lysed using the lysis reagent 
provided by the kit. To 50μl of cell lysate (transferred to white MTP plates), Luciferase enzyme 
(50µl) was added and Bioluminescence was measured using a luminometer (Fluoroscan Ascent 
FL). 
     % ATP level = (Bioluminescence of treated cells/Bioluminescence control cells) X 100.  
 
2.7 Mitochondrial Membrane Potential of MOE-treated Cells 
The effect of MOE on the integrity of mitochondrial membrane in HT29 cells was assessed 
using Mito PTTM JC-1 assay kit. Cells were seeded (l × l05cells/1ml) onto sterile glass cover slips 
placed in 12-well plates and treated with MOE at EC50 (0.03%). Media was aspirated and cells 
were incubated for 15 min at room temperature with 1x Mito PTTM JC-1 (300μl) stain solution 
(provided by kit), then washed twice with buffer solution, and visualized using a fluorescent 
microscope (OLYMPUS; BH2-RFCA), at an excitation of 490 nm and emission of 510 nm. 
Images were taken by OLYMPUS DP71 camera using the DP controller (OLYMPUS, 2001-2006; 
3.1.1.267) acquisition software. 
 
2.8 Cell Cycle Progression in MOE-treated HT29 Cells 
Cell cycle progression was assessed using PI staining and flow cytometry. HT29 were 
seeded in 100 mm petri dishes (1x106cells/10ml) and treated with MOE (0.03%) for 3, 6 and 
24hours. Cells were then trypsinized, centrifuged (1500 rpm for 5 min), washed with PBS, fixed 
in 70% ethanol (1d, -20ºC) then incubated at 4ºC (1hour) following the consecutive addition of 
RNase A (100 μl, 200 μg/ml), PBS (350µl) and PI (35µl, 1mg/ml). The fluorescence of the PI 
stained DNA was measured using Guava EasyCyte8 Flow Cytometer, collected as 10000 ungated 
events and the corresponding cell cycle distribution according to DNA content was determined. 
 
2.9 Annexin-V and Propidium Iodide Staining Assay 
Annexin-V and propidium iodide (PI) staining was used to determine the mode of cell death 
in MOE-treated HT29 cells. Briefly cells were seeded in 6- well plates (2×105cells/2 ml), treated 
for 3, 6, and 24hours with MOE at EC50 (0.03%), trypsinized, washed with PBS, re-suspended (5 
min) in Annexin-VFITC and PI containing binding buffer, at room temperature. The Annexin-V 
FITC−/PI− cell population was considered normal, whereas the Annexin-V FITC+/PI− and 
Annexin-V FITC+/PI+ were indicative of early and late apoptotic cells respectively. Flow 
cytometry data were analyzed by the fluorescence Guava EasyCyte8 Flow Cytometer- Millipore. 
 
2.10 Effect of Antioxidants on Viability, ROS, and LDH in MOE-treated HT29 Cells 
The protective effect of NAC (5mM) and the enzyme catalase (3.4 U/ml) on MOE-treated 
HT29 cells was examined. Cells were pretreated with either antioxidant, for 2hours prior to MOE 
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2.11 Effect of MOE on Related Colon Cancer Cells 
Different colon cancer cell lines (HCT116, Caco2, SW837 and SW948) were treated with 
MOE and compared with HT29 for viability as described before. 
 
2.12 Statistical analysis 
Results are reported as the mean ± standard error of the mean (SEM). Figure legends report 
on the number of determinations from the different number of experiments. Significance was 
determined using Microsoft Excel independent student t-test. p<0.05 were considered 
significant. The inter-categorical statistical significance and the significance relative to the 
control of each parameter were also analyzed by using independent student t-test. 
 
3. RESULTS 
Qualitative phytochemical analysis of the 1% Moringa oleifera (MOE) water extract identified 
the presence of: flavonoids, saponins, di-terpenes, phenols, and alkaloids (Table 1). While tannins 
were not detected in the 1% extract, they were identified in water extracts greater than 5% (Data not 
shown). 
 








Lead acetate Test Flavonoids + 
Shinoda Test Flavonoids + 
Honey Comb Test Saponins + 
Copper Acetate Test Diterpenes + 
FeCl3 Test Phenols + 
Tannic Acid Test Alkaloids + 
Gelatin Test Tannins - 
 
3.1 MOE Decreased the Viability of HT29 Cells 
MOE decreased in a dose dependent manner the viability of HT29 cells. Treating cells for 
6 hours with increasing MOE concentration caused significant (p<0.001) cell death (Figure 1A).  
Estimated EC50 was obtained at 0.03% with further decrease in viability reaching 70% at 0.05%. 
A similar dose dependent decrease in viability profile was obtained after 24 hours reaching 98% 
cell death at 0.05% MOE (Figure 1A).   
 
3.2 MOE-Treated HT29 Cells Induced LDH Release 
The integrity of plasma membrane was assessed by quantifying the level of LDH released 
from MOE-treated (0.03%) HT29 cells into culture media. The level of released LDH increased 
from 8% (p<0.01) to 48% (p<0.001) post MO-treatment for 6 and 24 hours respectively (Figure 
1B). 
 
3.3 Time Dependent Increase in ROS Level in MOE Treated HT29 Cells 
Treatment of HT29 with MOE (EC50) resulted in a time dependent gradual increase in 
ROS level. A significant increase in ROS level of 14.7% and 53% (p < 0.001) was obtained at 
3hours and 24hours post treatment respectively (Figure 1C). 
4






Fig. 1: Effect of MOE-treated HT29 cells on A) Viability using trypan blue exclusion assay. B) LDH 
released level C) Changes in ROS level with time. Data presented are the mean ± SEM of 9 
determinations of three different experiments. Asterisks on bars represent significance relative to the 
control, *P<0.05, **P<0.01, and ***P<0.001 respectively. 
 
 
3.4 MOE DECREASED ATP LEVEL AND DISSIPATED MITOCHONDRIAL 
MEMBRANE POTENTIAL IN HT29 CELLS 
The effect of MOE-treated HT29 cells on mitochondrial function was assessed by 
monitoring changes in ATP level, and membrane potential.  
MOE caused a time dependent decrease in ATP level (Figure 2A). A significant decrease 
of 42% (p<0.01) occurred after 6hours of treatment; with further decrease reaching 91% 
(p<0.001) at 24hours at EC50. It is known that dissipation of mitochondrial membrane potential 
would decrease ATP level. To verify whether the drop in ATP level at 6hours is consequent to 
dissipation of membrane potential we examined the effect of MOE on membrane potential at an 
earlier time point. Using Mito-JC1, healthy control cells stained red orange, whereas MOE-
treated HT29 cells showed increase in green stain indicating dissipation of mitochondrial 




Fig.2: Effect of MOE-treated HT29 on: A) Changes in ATP level with time using ATP Bioluminescence 
Assay. Data presented is the mean ± SEM of 6 determinations from three different experiments. Asterisks 
on bars represent significance relative to the control.  **P<0.01, and ***P<0.001 respectively. B) 
Mitochondrial Membrane Potential using MitoPTTM JC-1 kit; a representative image of 3 different 
experiments. 
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3.5 Cell Cycle Analysis of MOE Treated HT29 Cells 
We next examined the changes in cell cycle phases in MOE treated HT29 cells. Cell 
phases were analyzed over different time intervals: 3, 6, and 24hours (Figure 3). Compared to 
control cells, MOE treated HT29, showed a significant increase (3.6 fold) with time in preG0 
phase concomitant with a decrease (0.4 fold) in G2M phase. No significant fold change was 





Fig.3: Distribution of cell cycle phases in MOE-treated HT29 with time using PI flow cytometry. A) 
Representative figure of the variation in phases with time B) Representative histogram of the effect of 
MOE, at different time point. C) Fold change in cell cycle phases. Data presented are the mean ± SEM of 3 
different experiments. 
 
Next, to examine whether cell death is apoptotic or necrotic, the effect of MOE-treated 
HT29 was determined at 3, 6, and 24hours (Figure 4) using Annexin V-FITC PI staining. A 
significant increase in the percentage of cells in the late apoptosis (3 to 9-fold) was obtained, 
while the change of those that are undergoing necrosis was less significant (3.5 to 4.4 fold) at 3 




Fig.4: Apoptosis assessment in MOE-treated HT29 cells with time (3, 6 and 24hours) using Annexin-V PI:  
A) Representative image from one experiment. B) Fold change in cellular phase distribution in MOE treated 












3.6 Protective Effect of NAC But Not Catalase 
The protective effect of the antioxidants NAC and catalase in MOE-treated HT29 cells at 
EC50 (0.03%) was investigated (Figure 5). MOE induced cytotoxicity in HT29 cells. 
Pretreatment with NAC increased significantly the viability (50%-75%) (Figure 5A), decreased 
generated ROS level (Figure 5B), and completely suppressed (p<0.001) the MOE induced LDH 
release (from 52.8% to 2.8%) as shown in Figure 5C. Catalase on the other hand was less 
effective than NAC and showed variable effects on the HT29 cell line. It caused minimal 
increase/restoration (10%) in viability (Figure 5A), did not decrease ROS production (Figure 





Fig.5: Effect of NAC and catalase pre-treatment on MOE-treated HT29 cells on (A) Viability, (B) ROS, (C) 
LDH release. Cells were pre-treated with NAC (5mM), or catalase (3.4U/ml) for 2hours, prior to MOE 
treatment.  Data presented is the mean ± SEM of 9 determinations from three different experiments. Asterisks 




3.7 MOE Effect on Cell Viability of Other Colon Cancer Cell Lines 
The effect of MOE on related colon cancer cell (CCC) lines was examined. Cells tested 
included HCT116, Caco2, SW837 and SW948.The Estimated EC50 were: 0.02% HCT116 and 
Caco2; 0.01% for SW837 and 0.03% for SW948 (Table 2). 
 
 
                                             Table 2: Estimated EC50 of MOE-treated CCC 
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Interest in identifying novel natural drugs that are toxic to cancerous, but not to normal cells, 
have increased in the recent years in traditional medicine. Plants extracts have been used in the 
treatment of many ailments providing a source of low cost phytochemicals with effective therapeutic 
potential.  
Moringa oleifera has been recognized for its biological activity targeting multicellular sites and 
therapeutic values including anti-cancer (Charoensin, 2014). 
In this study, we have examined the anti-cancerous potential of MOE on HT29 cells; a model 
of intestinal epithelium human colon cancer cell lines (CCC) (De Luca et al., 2014). We hereby show, 
a dose dependent cytotoxic effect on MOE-treated HT29. MOE-induced cell death by: increasing 
ROS level and depolarizing in mitochondrial membrane potential (3hours), followed by a decrease in 
ATP level (6hours), at 24hours we obtained an increase in cell cycle preG0 phase and in late apoptotic 
events, with concomitant increase in LDH release (biomarker of necrotic event). Pre-treatment with 
anti-oxidant N-acetyl cysteine suppressed completely LDH release and significantly restored partial 
viability. We also tested the effect of MOE on other cell lines and they showed to be sensitive to 
treatment at different concentrations. 
In this study we opted to use water extract of MO despite the fact that concentration of extracted 
compound in organic solvents are much higher. Our aim was to mimic people consumption of MO 
leaves as herbal tea and studying its potential anti-cancerous effect. Previous studies have reported 
that aqueous Moringa leaf extracts are safe at high doses (Awodele et al., 2012). A perceptible dose 
and time dependent increase in cell death as for 6hours was obtained in MOE-treated HT29 cells with 
further increase at 24hours (Figure 1A). Our results are in agreement with previous reports on HepG2 
(Jung IL et al., 2015), A549 (Madi et al., 2016; Jung IL et al., 2015), HCT116 (Reda et al., 2017), 
and KB (Sreelatha & Padma, 2011) cancerous cell lines.  
Reactive oxygen species (ROS) are one of the important regulators of cell death and survival 
mechanisms (Raza et al., 2017). Following treatment with MOE, we obtained an early increase in 
oxidative stress (ROS) occurred as of 3 hours becoming incompatible with cell viability at 24hours 
(Figure 1C). A major source of ROS is the electron transport chain of mitochondria. The increase in 
ROS following MOE-treated HT29 was accompanied by an increase in mitochondrial membrane 
depolarization that was further confirmed by a decrease in ATP level at 6hours (Figure 2 A & B). 
Further decrease in ATP level was obtained at 24hours (Figure 2A). 
MOE-induced cytotoxicity however is not limited to derangement in mitochondrial membrane 
potential but it influenced as well the plasma membrane. A biomarker of damaged plasma membrane 
is associated with an increase in released lactate dehydrogenase extracellularly resulting from 
increased membrane permeability. In our study, LDH release was minimal after 6hours’ treatment of 
MOE but reached maximum of 50% after 24hours (Figure 1B) indicating a possible necrotic effect. 
To examine whether it is necrotic or apoptotic, quantitative analysis with time showed an increase in 
PreG0 (Cell cycle) and late apoptotic events with no time dependent variation in necrotic effect 
(Annexin-V PI) (Figure 3 and Figure 4). This was further confirmed following pretreatment with 
NAC, a GSH precursor which suppressed completely LDH release and restored partially and 
significantly cell viability indicating it is apoptotic rather than necrotic (Figure 5) and that the LDH 
released is considered as secondary necrosis due to apoptotic cells (caspase activity measured, data 
not shown). 
It is possible to suggest that the complete suppression of LDH release, and significant 
restoration of viability and ROS level) may be attributed to: a) promoting biosynthesis of intracellular 
GSH which decreases ROS and reverses induced cell death mechanism; b) interacting directly with 
thiol containing intracellular and plasma membrane bound  proteins involved in the MOE induced 
cell death; and c) neutralizing the pro-oxidant potential of MOE components at the expense of itself 
getting oxidized.  Regardless whether one or all of the possibilities are involved, the net result led to 
a protective effect against the induced cell death. On the other hand, pretreatment with catalase, a 
hydrogen peroxide metabolizing enzyme, exerted a minimal restoration in viability of HT29 cells 
(Figure 5), while had no effect on ROS and LDH levels indicating that H2O2 is not a major key player 










To sum up we hereby report the potential anti-cancerous effect of MOE on HT29 cell line and 
related CCC. MOE-induced cell death by simultaneous increase in intracellular oxidative stress and 
dissipation of mitochondrial membrane potential leading to decrease of ATP level and increase in 
plasma membrane permeability, suppression of LDH release by NAC pretreatment favors apoptotic 
rather than necrotic effect (Figure 6). Both cell cycle analysis and annexin-V PI results were 
confirmatory the extract-induced apoptotic events occurred in HT29 cells as well as related CCC 
suggest therapeutic potential of MOE in preventing or treating cancer. 
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